Hyperbaric Oxygen Therapy use in Mito Patients - 8/6/2010

June 22, 2022 01:27:40
Hyperbaric Oxygen Therapy use in Mito Patients - 8/6/2010
MitoAction Expert Series
Hyperbaric Oxygen Therapy use in Mito Patients - 8/6/2010

Jun 22 2022 | 01:27:40

/

Show Notes

Dr. Bruce Cohen from the Cleveland Clinic in Ohio discusses his perspective on the use of hyperbaric oxygen therapy, also known as HBOT, for people with mitochondrial disease.

Hyperbaric oxygen therapy is the use of 100% oxygen at a level higher than the atmosphere.  HBOT is controversial, and has long been used to treat some conditions, such as carbon monoxide poisoning, burn inuries, and decompression sickness. However, some studies propose that HBOT may play a positive role with other conditions, such as autism, cerebral palsy, brain injury, multiple sclerosis and others.

Some patients and parents ask, "Is hyperbaric oxygen therapy safe for a person with the diagnosis of mitochondrial disease?"

About the Speaker

Dr. Bruce Cohen, from the Cleveland Clinic in Ohio, is well known in the mitochondrial disease community.  In addition to his background in mitochondrial medicine, Dr. Cohen has an extensive background in conducting clinical trials for cancer treatment.

Other Episodes

Episode 0

November 06, 2020 01:14:01
Episode Cover

Diet, Dysmotility, and Tube Feeding - Kristen R. Roberts - 12/4/2015

Many children and adults with mitochondrial disease experience significant gastrointestinal or digestive issues as part of their daily disease challenges. When considering the pros...

Listen

Episode 0

August 25, 2021 00:59:38
Episode Cover

Introducing the Ultragenyx LC-FAOD Disease Monitoring Programs: Our Commitment to Advancing LC-FAOD Research Globally

Join MitoAction, Laura Pisani-Betancourt and Kristin Voorhees from Ultragenyx Pharmaceutical on Friday, July 9th, 2021 at 12:00pm EST for our monthly expert series presentation!...

Listen

Episode

April 12, 2022 01:22:18
Episode Cover

Multiple Specialists

MitoAction meeting discussing multiple specialists.

Listen